aflatoxin b1 has been researched along with naringin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barton, PT; Beamand, JA; Lake, BG; Price, RJ; Renwick, AB; Tredger, JM | 1 |
| Kang, Q; Liang, X; Liu, Q; Wang, W; Wang, Z | 1 |
2 other study(ies) available for aflatoxin b1 and naringin
| Article | Year |
|---|---|
Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human and rat liver slices.
Topics: 2-Acetylaminofluorene; Adult; Aflatoxin B1; Animals; Carcinogens; Child; Child, Preschool; DNA; DNA Repair; Female; Flavanones; Flavones; Flavonoids; Humans; Imidazoles; In Vitro Techniques; Liver; Male; Microsomes, Liver; Middle Aged; Mutagenicity Tests; Rats; Rats, Sprague-Dawley; Xenobiotics | 1999 |
Protective role of naringin loaded solid nanoparticles against aflatoxin B1 induced hepatocellular carcinoma.
Topics: Aflatoxin B1; Animals; Anti-Inflammatory Agents; Antioxidants; Carcinoma, Hepatocellular; Drug Carriers; Drug Liberation; Flavanones; Liver; Liver Neoplasms; Male; Nanoparticles; Rats, Wistar; Silymarin | 2022 |